Post-transplant lymphoproliferative disorders: T-cell lymphoma following cardiac transplant

被引:16
作者
Haldas, J [1 ]
Wei, WB [1 ]
Lazarchick, J [1 ]
机构
[1] Med Univ S Carolina, Div Haematol & Oncol, Dept Med, Charleston, SC 29403 USA
关键词
PTLD; heart transplantation; T-cell lymphoma; immunosuppression; Epstein-Barr virus;
D O I
10.1080/10428190290006332
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Post-transplant lymphoproliferative disorders (PTLD) are a frequently fatal complication occurring after transplant. The majority of cases are of B-cell origin but a smaller percentage of cases are of T-cell origin. The etiology of these disorders is unclear, however, EBV (Epstein-Barr virus) in the context of immunosupperssion is thought to play a role, particularly in B-cell PTLD. We report a case of T-cell PTLD limited to the bone marrow occurring eight years post-cardiac transplantation and review the literature on T-cell PTLD after heart transplant.
引用
收藏
页码:447 / 450
页数:4
相关论文
共 50 条
  • [41] Post-transplant complications -: Successful treatment of post-transplant lymphoproliferative disorder in autologous blood stem cell transplant recipients
    Jenkins, D
    DiFrancesco, L
    Chaudhry, A
    Morris, D
    Glück, S
    Jones, A
    Woodman, R
    Brown, CB
    Russell, J
    Stewart, DA
    BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 321 - 326
  • [42] Epstein-Barr virus-related lymphoproliferative disorders in T-cell repleted haploidentical transplantation with post-transplant cyclophosphamide
    Uygun, Vedat
    Ozsan, Nazan
    Daloglu, Hayriye
    Ozturkmen, Seda
    Yalcin, Koray
    Karasu, Gulsun
    Yesilipek, Akif
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (04) : 600 - 604
  • [43] Cutaneous T-cell lymphoma in a cardiac transplant recipient
    McMullan, DM
    Radovancevic, B
    Jackow, CM
    Frazier, OH
    Duvic, M
    TEXAS HEART INSTITUTE JOURNAL, 2001, 28 (03): : 203 - 207
  • [44] Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
    Major, Ajay
    Kamdar, Manali
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (07)
  • [45] Post-transplant lymphoproliferative disorders following liver transplantation: Incidence, risk factors and survival
    Kremers, WK
    Devarbhavi, HC
    Wiesner, RH
    Krom, RAF
    Macon, WR
    Habermann, TM
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (05) : 1017 - 1024
  • [46] A Post-transplant Immunosuppression Complication: Epstein-Barr Virus-Positive Classic Hodgkin Lymphoma Post-transplant Lymphoproliferative Disorder
    Zaver, Himesh B.
    Prakash, Gautham
    Plant, Samuel
    Chaudhari, Jigisha
    Erno, Jason
    Mithqal, Ayman
    Courville, Elizabeth
    Marchi, Enrica
    Henry, Zachary
    ACG CASE REPORTS JOURNAL, 2025, 12 (02)
  • [47] Managing Post-Transplant Lymphoproliferative Disorders in Solid-Organ Transplant Recipients A Review of Immunosuppressant Regimens
    Murukesan, Vidhya
    Mukherjee, Sandeep
    DRUGS, 2012, 72 (12) : 1631 - 1643
  • [48] Post-transplant lymphoproliferative disorders with naso- and oropharyngeal manifestation
    Akbas, Ayla
    Tiede, Christina
    Lemound, Juliana
    Maecker-Kolhoff, Britta
    Kreipe, Hans
    Hussein, Kais
    TRANSPLANT INTERNATIONAL, 2015, 28 (11) : 1299 - 1307
  • [49] PD-L1 and PD-1 expression in pediatric post-transplant Burkitt lymphoma and other monomorphic post-transplant lymphoproliferative disorders
    Geerlinks, Ashley V.
    Allen, Upton
    Ngan, Bo-Yee
    Punnett, Angela
    PEDIATRIC BLOOD & CANCER, 2023, 70 (12)
  • [50] Complete remission of immunochemotherapy-refractory monomorphic post-transplant lymphoproliferative disorder mediated by endogenous T-cell recovery
    Bishton, Mark J.
    Long, Heather M.
    Dowell, Alexander C.
    Meckiff, Benjamin J.
    Byrne, Catherine
    Fox, Christopher P.
    LEUKEMIA & LYMPHOMA, 2019, 60 (08) : 2075 - 2078